Navigation Links
Via Oncology Pathways Now Incorporate Advance Care Planning Decision Support
Date:5/4/2011

PITTSBURGH, May 4, 2011 /PRNewswire/ -- The most recent release of Via Oncology Pathways from D3 Oncology Solutions (D3) now includes decision support for advance care planning to encourage early discussions between oncologists and their patients about the disease, treatment intent and likely outcomes.

Recent articles on appropriate palliation and hospice have demonstrated positive effect that attention to planning end of life care can offer. One such study in oncology, a New England Journal of Medicine article by Temel JS et al, demonstrated over two months survival benefit to patients receiving less aggressive care in combination with symptom palliation in advanced non-small-cell lung cancer. 

Advance care planning can be an increasingly difficult conversation for physicians, patients and family members as the disease progresses, balancing the benefit of continued aggressive treatment with a realistic appraisal of the benefit.  "Via Oncology Pathways raise the topic of advance care planning early in the process before treatments begin to ensure the patient has the best chance to make well informed and thoughtful decisions," said Kathleen Lokay, president, D3 Oncology Solutions.

The addition of the advance planning feature prompts the oncologist to record whether the intent of a patient's treatment was curative or non-curative, and whether that intent was discussed with the patient. Additionally, for all patients with late stage disease, hospice or palliative care is prioritized as a pathway consideration each time the physician sees the patient. The oncologist, however, always maintains control with respect to when and how to broach the conversation with a patient make choices for end of life care.  

"The advance care planning feature is designed to help foster candid discussions between the patient and physician about the realistic prognosis of late-stage disease and the costs versus benefits of additional therapies that are often accompanied by debilitating side effects," said Lokay. "Advance care planning encourages the patient and physician to have this all-important discussion of the risks and benefits of treatment options with the goal of maximizing quality of life."

Currently, D3's Via Oncology Pathways cover more than 85 percent of cancer diagnoses and include chemotherapy and biologics, radiation therapy, prognostic testing, supportive care treatments and advance care planning. All aspects of the pathways are delivered through a web-based, patient-specific, point of care decision support tool that integrates into the practice's other information technologies. Additionally, advance care planning support is seamlessly built into the software to support the physician's workflow.

About D3 Oncology Solutions

The mission of D3 Oncology Solutions is to develop and deliver leading edge solutions that accelerate the quality, safety, efficiency and outcomes of cancer patients' care at radiation and medical oncology centers around the world.

With unmatched expertise for more than a decade, D3 has assisted hundreds of cancer centers in the United States and internationally. D3's solutions are guided by close collaboration with leading radiation oncologists, medial oncologists and medical physicists at UPMC and UPMC Cancer Centers.

From flexible options for linear accelerator commissioning, clinical training and radiation treatment planning to tools and programs that support clinical quality such as Via Oncology Pathways, D3's suite of solutions accelerates excellence in the delivery of cancer care.  

D3 is an affiliate of UPMC, an integrated global health enterprise headquartered in Pittsburgh and one of the leading health systems in the United States. For more information, visit www.d3onc.com or call (412) 365-0710.


'/>"/>
SOURCE D3 Oncology Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Medical Imaging Technologies for Oncology Diagnostics: The Global Market
2. Access Pharmaceuticals to Attend the 36th Annual Oncology Nursing Society Congress
3. Cancer Centers of North Carolina Acquires Wake Radiology Oncology Services of Cary, N.C.
4. GTG Announces New Product Collaboration with Global Pharmaceutical Company for Companion Diagnostics in Oncology
5. Oncology Global Strategic Marketing Study Offers Chance for Resource Benchmarks
6. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
7. California Oncology Group Uses New Technology to Choose Best Cancer Treatment
8. Silence Therapeutics Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting
9. Advancements in GYN Oncology; Instrumentation and Techniques to be Presented by Nicholas C. Lambrou, M.D. of Miami
10. Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors
11. Lilly Announces New Vice President of Oncology Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... -- Research and Markets has announced the addition of the ... ... report analyzes the worldwide markets for Endodontic Supplies in US$ Thousand. The report ... Japan , Europe , Asia-Pacific ... Annual estimates and forecasts are provided for the period 2015 through 2022. Also, ...
(Date:12/8/2016)... 8, 2016 Bodycad announced it has ... the accuracy, reproducibility and speed for 3D constructs ... small bone orthopaedic applications. These patents are critical ... orthopaedic restorations based on each patient,s distinct anatomy. ... company harnesses the world,s first suite of orthopaedic ...
(Date:12/8/2016)... , Dec. 8, 2016 True ... that brings leading-edge laboratory services and management expertise ... States , allowing more doctors and patients ... care management solutions. Logo - ... Hospital systems, under pressure to contain costs, ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... December 10, 2016 , ... "TransPanel Volume 2 is a package ... said Christina Austin - CEO of Pixel Film Studios. , TransPanel Volume 2 ... . This set of versatile transitions features presets with up to 4 panels ...
(Date:12/10/2016)... ... December 10, 2016 , ... When faced with having to use a toilet ... seat to her body, and contamination of children when they use public toilets. This ... problem that many people face. , The patent-pending SANI-POCKET enables a person to use ...
(Date:12/9/2016)... ... December 09, 2016 , ... Cellairis is a worldwide mobile device and ... iPhone , iPad and Samsung Galaxy devices with premium parts and accessories. ... to maximize convenience and accessibility for customers. While customers do their shopping, Cellairis can ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... The ... Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits and ... the District of Columbia as an education tool in the war against teen drug ...
(Date:12/9/2016)... New York, NY (PRWEB) , ... December 09, 2016 , ... ... that raises awareness for organ transplantation while encouraging readers to sign up as an ... for a lifesaving organ transplant. , An organ donor can save up to ...
Breaking Medicine News(10 mins):